Abingworth LLP PHAT Holdings History

Number of Shares
1.44 Mil
Current Holdings Value*
$16.10 Mil
% of Portfolio
5.25%
Total Estimate Gain
$-36.79 Mil
% of Total Estimate Gain
-74.06%

Abingworth LLP's Phathom Pharmaceuticals Inc Holding Summary

As of 2022-12-31, Abingworth LLP held 1.44 Mil shares of Phathom Pharmaceuticals Inc(PHAT), totaling $16.10 Mil. This investment constitutes 5.25% of their stock portfolio, and Abingworth LLP now holds 3.45% of the outstanding Phathom Pharmaceuticals Inc(PHAT) stock.

The initial trade took place in 2020Q2. And since then Abingworth LLP has made 2 purchases of PHAT, at an average price of $34.61, for a total of 1.44 Mil shares. Based on historical transaction data and PHAT's current price of $8.98, Abingworth LLP's estimated gain on his PHAT holdings is $-36.79 Mil, reflecting a -74.06% gain to date.

Abingworth LLP PHAT ($8.98) Holding Chart

Abingworth LLP PHAT ($8.98) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1